Global Peripheral Stent Systems Market Size By Type (Nitinol, Cobalt-Chromium), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Peripheral Stent Systems Market was valued at USD 4.2 billion in 2023 and is projected to reach USD 7.1 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. This growth is driven by the increasing incidence of peripheral artery disease (PAD), rising geriatric population, and the growing preference for minimally invasive surgical procedures. Peripheral stent systems are widely used to restore blood flow in narrowed or blocked peripheral arteries, improving patient outcomes and reducing recovery time compared to traditional surgery.

Drivers

Rising Prevalence of Peripheral Artery Disease (PAD):

The growing number of PAD cases globally, particularly among aging populations and patients with diabetes, is significantly boosting the demand for peripheral stent systems.

Technological Advancements in Stent Design:

The development of bioresorbable stents, drug-eluting stents, and next-generation flexible stents with enhanced deliverability and durability is propelling market expansion.

Minimally Invasive Surgical Trend:

The global healthcare sector’s shift toward minimally invasive procedures due to shorter hospital stays, lower infection risks, and quicker recovery is increasing stent system adoption.

Restraints

High Cost of Advanced Stent Systems:

Premium pricing associated with technologically advanced stents can limit their adoption, especially in cost-sensitive emerging markets.

Complications and Regulatory Hurdles:

Despite benefits, stent implantation can result in complications like restenosis or thrombosis. Additionally, stringent regulatory frameworks for stent approval can delay market entry.

Opportunity

Growing Demand in Emerging Economies:

Countries in Asia-Pacific and Latin America offer significant untapped potential due to rising healthcare investments, growing awareness, and increasing access to vascular care.

Integration of AI and Imaging for Precision Stenting:

Combining AI-driven diagnostics with high-resolution imaging is paving the way for precision-guided stent placements, creating a new frontier for clinical adoption.

Market by System Type Insights

The Self-expanding Stents segment held the largest market share in 2023, attributed to their flexibility, ease of deployment, and suitability for complex anatomical areas. These stents are particularly beneficial for patients with tortuous or long arterial lesions.

The Balloon-expandable Stents segment is expected to grow rapidly during the forecast period, driven by their precision in placement and increasing use in renal and iliac artery interventions.

Market by End-use Insights

In terms of end-use, the Hospitals and Surgical Centers segment dominated the market in 2023, owing to the availability of skilled interventional radiologists and advanced facilities. The segment is projected to maintain its dominance with the expansion of vascular surgery units globally.

Ambulatory Surgical Centers (ASCs) are poised for significant growth, supported by the increasing adoption of outpatient endovascular procedures due to their cost-effectiveness and faster patient turnaround.

Market by Regional Insights

North America led the market in 2023, driven by a high prevalence of PAD, favorable reimbursement policies, and advanced healthcare infrastructure. The U.S. remains a critical contributor due to early adoption of next-gen stent systems.

Asia-Pacific is projected to exhibit the highest CAGR during the forecast period. Increasing healthcare awareness, a rising diabetic population, and rapid infrastructure development are key growth catalysts in countries like China and India.

Competitive Scenario

Key players in the Global Peripheral Stent Systems Market include:

Medtronic plc

Boston Scientific Corporation

Abbott Laboratories

Cook Medical

Terumo Corporation

Becton, Dickinson and Company (BD)

Biotronik SE & Co. KG

Cardinal Health

Gore Medical

iVascular

These companies are focused on expanding their product portfolios through R&D, obtaining regulatory approvals, and forging strategic collaborations to enhance global reach.

Scope of Work – Global Peripheral Stent Systems Market

Report Metric Details

Market Size (2023) USD 4.2 billion

Projected Market Size (2031) USD 7.1 billion

CAGR (2023–2031) 6.5%

Market Segments By System Type, End-use, Region

Growth Drivers Rising PAD cases, Minimally invasive surgeries, Technological advancements

Opportunities AI-guided procedures, Emerging market expansion

Key Market Developments

2023: Medtronic launched its latest-generation self-expanding peripheral stent with improved radial strength and precision delivery for superficial femoral artery lesions.

2024: Abbott received FDA clearance for its new drug-eluting peripheral stent platform with enhanced anti-restenosis properties.

2025: Boston Scientific announced a strategic partnership with a health-tech firm to integrate AI imaging into stent placement planning for peripheral procedures.

FAQs

1) What is the current market size of the Global Peripheral Stent Systems Market?

The market was valued at USD 4.2 billion in 2023.

2) What is the major growth driver of the Global Peripheral Stent Systems Market?

The primary driver is the increasing incidence of peripheral artery disease (PAD) and the rising demand for minimally invasive vascular interventions.

3) Which is the largest region during the forecast period in the Global Peripheral Stent Systems Market?

North America holds the largest market share due to advanced healthcare systems and higher PAD prevalence.

4) Which segment accounted for the largest market share in the Global Peripheral Stent Systems Market?

The Self-expanding Stents segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Peripheral Stent Systems Market?

Leading players include Medtronic, Boston Scientific, Abbott, Cook Medical, Terumo, and BD.